Early antibody treatment, inflammation, and risk of post-COVID conditions

By sjmartinez • September 20, 2023

Gebo KA, Heath SL, Fukuta Y, Zhu X, Baksh S, Abraham AG, Habtehyimer F, Shade D, Ruff J, Ram M, Laeyendecker O, Fernandez RE, Patel EU, Baker OR, Shoham S, Cachay ER, Currier JS, Gerber JM, Meisenberg B, Forthal DN, Hammitt LL, Huaman MA, Levine A, Mosnaim GS, Patel B, Paxton JH, Raval JS, Sutcliffe CG, Anjan S, Gniadek T, Kassaye S, Blair JE, Lane K, McBee NA, Gawad AL, Das P, Klein SL, Pekosz A, Bloch EM, Hanley D, Casadevall A, Tobian AAR, Sullivan DJ; CSSC-004 Consortium. Early antibody treatment, inflammation, and risk of post-COVID conditions. mBio. 2023 Sep 19:e0061823. doi: 10.1128/mbio.00618-23. Epub ahead of print. PMID: 37724870.

Tags: chemokines, covid-19, COVID-19 serotherapy, Cytokines, Infectious Diseases, Interleukin-6, post-acute sequelae of COVID (PASC), post-COVID condition (PCC), Publications

Diagnostic Value of Inter-Eye Difference Metrics on OCT for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis

Volpe G, Jurkute N, Girafa G, Zimmermann HG, Motamedi S, Bereuter C, Pandit L, D'Cunha A, Yeaman MR, Smith TJ, Cook LJ, Brandt AU, Paul[...]

Control strategies for emerging infectious diseases: Crimean-Congo hemorrhagic fever management

Srivastava S, Kumar S, Sharma PK, Rustagi S, Mohanty A, Donovan S, Henao-Martinez AF, Sah R, Franco-Paredes C. Control strategies for emerging infectious diseases: Crimean-Congo[...]

Single-cell detection of copy number changes reveals dynamic mechanisms of adaptation to antifungals in Candida albicans

Zhou X, Hilk A, Solis NV, Scott N, Beach A, Soisangwan N, Billings CL, Burrack LS, Filler SG, Selmecki A. Single-cell detection of copy number[...]